MEDICAL DEVICES GLOBAL {MDG}

Challenges for radiology


A series of reports by the Parliamentary Service and the Ombudsman, the Royal College of Radiologists (RCR) and Professor Sir Mike Richards' independent evaluation of diagnostic services for the NHS in England highlighted major concerns to be addressed in radiology. pandemic. It is clear from this report that there are many obstacles that need to be overcome, especially with regard to the backlogs needed to scan and optimize workflows for doctors and radiologists.


According to the NHS, 34 million imaging studies were reported in England over the 12 months from April 2020 to March 2021, in contrast to the 44.9 million imaging studies reported in England in the year to March 2019. The Lung Health Working Group estimates that 20 % of patients with lung disease wait for a prognosis for more than a year. NHS England data suggest that almost 400,000 patients have been waiting for more than a year to start cancer treatment - the highest number since December 2007.


Other major challenges for radiology were outlined by Rob Behrens, chairman of the parliamentary and health ombudsman, and noted in his report: “The results of X-rays and scans are key to the diagnosis and treatment of many people. that without a concerted effort to improve imaging, patient safety remains compromised.


A key issue is one of the incoherent health cascades that results in health care interoperability. During treatment, patients can visit a family doctor, radiologist, breast specialist and oncologist. Each of them will contribute to the analysis and diagnosis of the patient, which will lead to a paper route - if this data is not collected in one place, the diagnosis and eventually treatment will be delayed.


The RCR welcomed these findings as it presented the results of a study it carried out on the characteristics of radiologists in the United Kingdom. 58% of radiology experts say they do not have enough diagnostic and interventional radiologists to keep patients safe.


44% deficit in the planned number of radiologists in 2025, unless more radiologists are trained.


In his report, Professor Sir Mike Richards, a former NHS Cancer Tsar, outlined the range of issues to be addressed. He predicted that CT scanning capacity in the NHS should increase over the next five years.


Addressing the shortcomings, reporting and interoperability in healthcare is difficult and there is no single solution that can meet all the operational, technological and personnel challenges of radiology. However, we at Qure.ai believe that artificial intelligence (AI) has the potential to reduce inefficiencies and optimize workflows, leading to increased productivity and increased physician confidence.


Use of AI for lung cancer screening


Lung cancer is the most common type of cancer worldwide. The aggressive nature and lack of early, visible symptoms often lead to delays in diagnosis and treatment and adverse consequences. Although common risk factors such as smoking are the main causes of lung cancer, aspects such as genetic predisposition, poor diet, working research and air pollution can be challenging to determine the likelihood of lung cancer patients.


Early diagnosis of the disease further increases the chance of survival and allows the introduction of less invasive medication than intervention. Systematic population screening can help diagnose abnormal lung outcomes, use confirmatory tests as effectively as possible, and identify cancer in the early stages. Early analysis can benefit individuals, their families and society.


However, early detection of lung cancer is difficult because:

  • Diagnosing cancer by conventional methods is an expensive procedure
  • The workload of doctors makes in-depth diagnostics difficult
  • Cancer screening during a routine examination is lengthy and easily interchangeable
  • Pulmonary node screening is not part of current medical protocols

Artificial intelligence can address the challenges of radiologists by automating the process of detecting malignant lesions. It can help clients with healthcare interoperability issues such as misdiagnosis, analysis, reporting, identification of common findings, and reduced time constraints.


A typical patient journey


When it comes to lung cancer, there are protocols that require regular screening of at-risk patients. In one possible scenario, the GP may see the area of care on an X-ray, but may not decide on the patient's recommendation. If artificial intelligence is involved in the course of the work, you can raise any concerns when searching for various findings, including pulmonary nodules.


If the patient is hospitalizing that AI helps to follow the scanning and help wounds over time. Suspicious nodes can be found at algorithms based on recommended parameters recommended by radiology and cancer company. This may be a score to determine the risk of chopped bank cancer of Longke New cancer (NSCLC).


The technology also designed to be easy and convertible AI. This means that the decision of the decision, known, not a metaphorical black entity that cannot be translated. For example, we have built our software, so it can describe those who know that the same way in the same way, the leading medical school discusses the problem.


AI refers to which annotations were observed, then mixed with reporting message. The decision to use observation or modification is in a radio login or clinic responsible for acquiring other steps in the passage.


More obvious image


Anyone who deals with the treatment of lung cancer understands the importance of early excitement and diagnosis. The main benefit of solving speed AI diagnosis because the cost of lung cancer changes as cancer begins. Quick results make it easy to follow referrals for further examinations, allowing physicians to optimize their time and relieve patients of anxiety when scans are normal.


This will not only help keep screening costs to a minimum, but will also reduce the burden of direct and indirect costs on individuals and the economy.